CD8A and hepatocellular carcinoma: Indeed, it may contribute to the observed enrichment of CD8+ T‐cell responses in patients with early stage HCC and supports the view that the release of autologous TAA can induce and/or boost TAA‐specific CD8+ T‐cell responses.15